University of California, Berkeley
Welcome,         Profile    Billing    Logout  
 13 Trials 
43 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
McBurnett, Keith
NCT05202327: PDC-1421 Treatment in Adult Patients With ADHD

Completed
2
70
US, RoW
PDC-1421 Capsule, Extract of Radix Polygalae, Placebo, Corn Starch
BioLite, Inc., ABVC BioPharma, Inc
Attention-Deficit Hyperactivity Disorder (ADHD)
12/23
12/23
Harvey, Allison G
MTurk, NCT05070143: Mini-treatment Experiments to Clarify How to Assist People to Habit Formation

Completed
N/A
286
US
RISE-UP Routine, Awareness Training, Vigilant Monitoring, Implementation Intentions, Values-based Approach, Brief Education
University of California, Berkeley
Sleep Disorder, Circadian Dysregulation, Habit, Good Sleep
05/23
05/23
NCT04154631: Implementing and Sustaining a Sleep Treatment to Improve Community Mental Part 1: Implementation Health Outcomes

Completed
N/A
459
US
Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), Usual Care Delayed Treatment
University of California, Berkeley
Sleep Disorder, Circadian Dysregulation
12/23
12/23
NCT05805657: Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer

Completed
N/A
143
US
Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), Usual Care Delayed Treatment
University of California, Berkeley
Sleep Disorder, Circadian Dysregulation
05/24
05/24
NCT05956678: Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 3: Sustainment

Completed
N/A
130
US
Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
University of California, Berkeley
Sleep Wake Disorders, Circadian Rhythm Disorders
04/24
04/24
NCT05167695: Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention

Recruiting
N/A
160
US
Habit-based Sleep Health Intervention, Text messaging intervention
University of California, Berkeley
Circadian Dysregulation
12/25
07/26
NCT05986604: NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment

Recruiting
N/A
178
US
Memory Support Intervention, MSI, Transdiagnostic Intervention for Sleep and Circadian Dysfunction, TranS-C
University of California, Berkeley
Sleep Disorder, Circadian Dysregulation, Memory Impairment
02/28
07/28
Mitchell, Jennifer
Voyage, NCT06741228: A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (VOYAGE)

Recruiting
3
200
US
Placebo, MM120 (LSD D-Tartrate)
Mind Medicine, Inc.
Generalized Anxiety Disorder
05/26
11/26
SnS, NCT06626139: Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers

Recruiting
2
120
US
Psilocybin, Context 1, Context 2, Placebo
Robin Carhart-Harris, PhD, MA
Healthy Participants with Lower-than-average Mental Well-being
11/27
11/28
MPLONG, NCT05066282: Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD

Completed
N/A
186
Canada, US, RoW
Lykos Therapeutics
PTSD
05/24
05/24
WB, NCT05963607: RCT of a Weighted Blanket to Reduce Pain in Veterans With Chronic Pain

Recruiting
N/A
160
US
Weighted blanket
VA Office of Research and Development
Chronic Pain, Sleep Disturbance
04/29
09/29
Hsu, Ming I
NCT04205994: Dopaminergic Mechanisms Underlying Human Social Behavior

Completed
1
70
US
Tolcapone 200 MG, Functional Magnetic Resonance Imaging (fMRI)
University of California, Berkeley, University of California, San Francisco, Lawrence Berkeley National Laboratory
Decision Making, Executive Function, Dopamine
12/23
12/23
MusiCare, NCT04851028: Music Therapy & Innovative Technology

Active, not recruiting
N/A
200
Europe
Music Therapy
Middlesex University, The Dunhill Medical Trust, University of Padova, Vrije Universiteit Brussel, University of Dublin, Trinity College
Healthy Aging, Cognitive Impairment
04/24
05/24
Cohen, Daniel
NCT05987007: Sleep Interventions and Neurocognitive Outcomes

Not yet recruiting
N/A
50
US
Acoustic slow-wave activity enhancement, Cognitive behavioral therapy for insomnia
New York State Psychiatric Institute, Columbia University
Sleep Disturbance, Amnestic Mild Cognitive Impairment
12/27
12/27
NoMAD, NCT03900273: Development of Novel Measures for Alzheimer's Disease Prevention Trials

Active, not recruiting
N/A
400
US
No Practice Effects (NPE) cognitive battery, and Miami Computerized Functional Assessment Scale (CFAS), Preclinical Alzheimer's Cognitive Composite (PACC), Alzheimer's Disease Assessment Scale-Cognitive Scale (ADAS-Cog), and Functional Assessment Questionnaire (FAQ)
New York State Psychiatric Institute, Columbia University, University of Southern California, Feinstein Institute for Medical Research, University of Miami
Healthy Participants
08/25
08/25
Rodriguez, Hector
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

Completed
4
339
US
Dronedarone, Multaq
American Heart Association, Duke Clinical Research Institute, Sanofi
Atrial Fibrillation
01/24
06/24
Silver, Michael
NCT05018117: Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex

Recruiting
1
48
US
Nicotine gum, polacrilex, Placebo gum
University of California, Berkeley, National Institute on Aging (NIA)
Aging
12/25
12/25
NCT05265546: Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain

Recruiting
1
80
US
Psilocybin
University of California, Berkeley
Perception Disorders
12/25
12/25
Fisher, Aaron
STRIDES, NCT05490563: - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia

Terminated
2/3
23
Europe, US, RoW
SLS-005, Placebo
Seelos Therapeutics, Inc.
Spinocerebellar Ataxia Type 3
11/23
11/23
NCT03759678 / 2018-004407-39: N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)

Recruiting
2
39
Europe, US
IB1001, N-Acetyl-L-Leucine
IntraBio Inc
Ataxia Telangiectasia, Louis Bar Syndrome
12/24
03/25
SUNRISE-FA, NCT05445323: Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

Active, not recruiting
1/2
8
US
Low dose LX2006, Mid Dose LX2006, High Dose LX2006
Lexeo Therapeutics
Friedreich Ataxia, Cardiomyopathy, Secondary
09/29
09/29
IDEA, NCT04268147: Instrumented Data Exchange for Ataxia Study

Completed
N/A
128
US
University of Chicago, Pfizer, Biogen, APDM Wearable Technologies
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6, Friedreich Ataxia
04/24
06/24
NCT05953779: Personalized Need-focused Single Session Intervention

Recruiting
N/A
240
US, RoW
Clinician-administered Need-focused Single Session Intervention
Bar-Ilan University, Israel, University of California, Berkeley, United States - Israel Binational Science Foundation
Depression and/or Anxiety in the Mild-to-moderate Range
07/24
09/24
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Recruiting
N/A
35000
Europe, Canada, US, RoW
CHDI Foundation, Inc.
Huntington's Disease
01/62
01/62
Lee, Jerry W
NCT06160791: Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

Recruiting
2
36
US
Ruxolitinib, INCB18424, Oral JAK, Etoposide, Toposar, Lastet, Dexamethasone, Dexa, Non-interventional Imaging, Ultrasound, Magnetic resonance imaging (MRI), Research Biopsy, Biopsy, Biospecimen Collection, Specimen collection
Aaron Logan, MD, Incyte Corporation
Hemophagocytic Lymphohistiocytoses
11/27
11/27
Levenson, Robert W
NCT05159583: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Rural Homes

Completed
N/A
15
US
In-Home Technology System, Limited In-Home Technology
University of California, Berkeley, People Power Company, National Institute on Aging (NIA), University of California, San Francisco
Dementia, Mild Cognitive Impairment, Alzheimer Disease
01/24
01/24
NCT05159557: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Wearables

Completed
N/A
63
US
In-Home Technology System, Limited In-Home Technology
University of California, Berkeley, People Power Company, National Institute on Aging (NIA), University of California, San Francisco
Dementia, Mild Cognitive Impairment, Alzheimer Disease
03/24
03/24
NCT05159596: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes

Completed
N/A
8
US
In-Home Technology System, Limited In-Home Technology
University of California, Berkeley, People Power Company, National Institute on Aging (NIA), University of California, San Francisco
Dementia, Mild Cognitive Impairment, Alzheimer Disease
10/23
10/23
Newton, Scott L
NCT05159583: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Rural Homes

Completed
N/A
15
US
In-Home Technology System, Limited In-Home Technology
University of California, Berkeley, People Power Company, National Institute on Aging (NIA), University of California, San Francisco
Dementia, Mild Cognitive Impairment, Alzheimer Disease
01/24
01/24
NCT05159557: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Wearables

Completed
N/A
63
US
In-Home Technology System, Limited In-Home Technology
University of California, Berkeley, People Power Company, National Institute on Aging (NIA), University of California, San Francisco
Dementia, Mild Cognitive Impairment, Alzheimer Disease
03/24
03/24
NCT05159596: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes

Completed
N/A
8
US
In-Home Technology System, Limited In-Home Technology
University of California, Berkeley, People Power Company, National Institute on Aging (NIA), University of California, San Francisco
Dementia, Mild Cognitive Impairment, Alzheimer Disease
10/23
10/23
Harvery, Allison G
NCT05668481: Improving Patient Memory for Treatment for Mild Cognitive Impairment

Recruiting
N/A
80
US
Transdiagnostic sleep and circadian intervention (TranS-C)
University of California, Berkeley
Memory Impairment, Sleep Disorder
06/26
06/26
Nagarajan, Srikantan S
NCT05216770: Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor

Recruiting
1
165
US
Brain imaging, Laryngeal sensory block with topical bupivacaine
Massachusetts Eye and Ear Infirmary, University of California, San Francisco
Laryngeal Dystonia, Spasmodic Dysphonia, Tremor
08/26
08/26
NCT03972202: The Role of Cerebellum in Speech

Active, not recruiting
N/A
660
US
MRI, Magnetic Resonance Imaging, TMS, Transcranial Magnetic Stimulation, Repetitive TMS, rTMS, Speech-motor behavioral testing
University of California, San Francisco, University of California, Berkeley, National Institute on Deafness and Other Communication Disorders (NIDCD), University of Wisconsin, Madison
Cerebellar Ataxia, Dysarthria, Healthy
05/25
05/25
Ivry, Richard
NCT03972202: The Role of Cerebellum in Speech

Active, not recruiting
N/A
660
US
MRI, Magnetic Resonance Imaging, TMS, Transcranial Magnetic Stimulation, Repetitive TMS, rTMS, Speech-motor behavioral testing
University of California, San Francisco, University of California, Berkeley, National Institute on Deafness and Other Communication Disorders (NIDCD), University of Wisconsin, Madison
Cerebellar Ataxia, Dysarthria, Healthy
05/25
05/25
Parrell, Ben
NCT03972202: The Role of Cerebellum in Speech

Active, not recruiting
N/A
660
US
MRI, Magnetic Resonance Imaging, TMS, Transcranial Magnetic Stimulation, Repetitive TMS, rTMS, Speech-motor behavioral testing
University of California, San Francisco, University of California, Berkeley, National Institute on Deafness and Other Communication Disorders (NIDCD), University of Wisconsin, Madison
Cerebellar Ataxia, Dysarthria, Healthy
05/25
05/25
Whitney, David
NCT04332783: Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search

Recruiting
N/A
1650
US
psychophysics of sequential biases (no drug or patient work)
University of California, Berkeley
Vision
03/25
03/26
Ekko, Valerie
NCT04332783: Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search

Recruiting
N/A
1650
US
psychophysics of sequential biases (no drug or patient work)
University of California, Berkeley
Vision
03/25
03/26
Massih, Yasaman
NCT06348056: A Comparison of the Metabolic Effects of Zinc-Amino Acid (ZnAA) Versus Zinc Gluconate

Recruiting
N/A
30
US
30 mg Zn Amino Acid daily for 13 days, 30 mg Zn Gluconate daily for 13 days
University of California, Berkeley
Response of Fatty Acid Desaturation to Zinc Intake
08/24
12/24
Ausiello, Jenna
NCT05265546: Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain

Recruiting
1
80
US
Psilocybin
University of California, Berkeley
Perception Disorders
12/25
12/25
Morello-Frosch, Rachel
NCT05746169: Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health

Recruiting
N/A
10000
US
Health Questionnaires, Specimen sample collection, Biospecimen sample collection, Specimen collection
University of California, San Francisco, National Cancer Institute (NCI), California Office of Environmental Health Hazard Assessment (OEHHA)
Cancer
08/27
08/27
Conboy, Irina
CARE, NCT06716411: Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness

Not yet recruiting
N/A
200
US
Acupuncture
University of Utah, United States Department of Defense, University of California, Berkeley, Beth Israel Deaconess Medical Center
Persian Gulf Syndrome, Gulf War Syndrome, Multiple Chronic Illnesses, Occupational Diseases, War-Related Injuries, Wounds and Injuries
09/26
09/28
Staff, BCSP Research
NCT05265546: Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain

Recruiting
1
80
US
Psilocybin
University of California, Berkeley
Perception Disorders
12/25
12/25

Download Options